Elemental secures MIS3 Framework

Surgical Innovations Group plc (AIM: SUN), the designer, manufacturer and distributor of innovative medical technology for minimally invasive surgery ("MIS"), announces that its wholly owned subsidiary, Elemental Healthcare Ltd ("Elemental") has been awarded a place on the NHS Minimally Invasive Surgery 3 ("MIS3") framework agreement for an initial period of two years, commencing on 10 August 2026.

This follows the Group's successful participation in the previous NHS MIS1 and MIS2 framework agreements, providing customers with greater product choice. This win reinforces Elemental Healthcare's long-standing position as a trusted supplier within the minimally invasive surgery sector, with its cost-effective procedure-specific surgical instruments.

The MIS3 framework provides streamlined access to NHS procurement channels via NHS Supply Chain, supporting efficient purchasing processes for NHS trusts across the UK. Currently, over 60% of Elemental Healthcare's sales are driven through this key framework, highlighting its strategic importance to the business and illustration of the trusted supplier they are, although it should be noted that this inclusion does not guarantee sales.

In addition to MIS3, Elemental Healthcare continues to hold equivalent framework agreements across Scotland and Wales, ensuring broad national coverage and access across the UK healthcare system, helping surgeons nationwide with their minimal invasive surgery procedures.

Commenting on the award, David Marsh, CEO of Surgical Innovations, said: "This framework award represents a significant achievement for the Group, enabling us to continue to compete effectively in this critical and growing healthcare sector. The Group remains focused on delivering high-quality products and services to NHS partners and looks forward to continuing its strong track record within the minimally invasive surgery market."